Cargando...
In-silico drug repurposing for targeting SARS-CoV-2 main protease (M(pro))
COVID-19, caused by novel coronavirus or SARS-CoV-2, is a viral disease which has infected millions worldwide. Considering the urgent need of the drug for fighting against this infectious disease, we have performed in-silico drug repurposing followed by molecular dynamics (MD) simulation and MM-GBSA...
Gardado en:
| Publicado en: | J Biomol Struct Dyn |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Taylor & Francis
2020
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7678360/ https://ncbi.nlm.nih.gov/pubmed/33179568 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/07391102.2020.1844058 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|